Terms: = Thyroid cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
22 results:
1. Family history of malignant or benign thyroid tumors: implications for surgical procedure management and disease-free survival.
Jiang YJ; Han ZJ; Hu YX; Zhang N; Huang T
Front Endocrinol (Lausanne); 2023; 14():1282088. PubMed ID: 38093963
[TBL] [Abstract] [Full Text] [Related]
2. Are nonfunctioning adrenal incidentalomas really nonfunctioning? A retrospective single-center study.
Güneş E; Güneş M
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9895-9901. PubMed ID: 37916357
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
Ye T; Lai S; Cao B; Xu B; Wang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
[No Abstract] [Full Text] [Related]
4. Case Report: Giant thyroid Angiolipoma-Challenging Clinical Diagnosis and Novel Genetic Alterations.
Wilkins R; Zan E; Leonardi O; Patel KN; Jacobson AS; Jour G; Liu CZ; Zhou F
Head Neck Pathol; 2023 Mar; 17(1):246-252. PubMed ID: 36255668
[TBL] [Abstract] [Full Text] [Related]
5. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the thyroid.
Bae JS; Jung SH; Hirokawa M; Bychkov A; Miyauchi A; Lee S; Chung YJ; Jung CK
Endocr Pathol; 2021 Sep; 32(3):336-346. PubMed ID: 34313965
[TBL] [Abstract] [Full Text] [Related]
6. Menstrual, reproductive and hormonal factors and thyroid cancer: a hospital-based case-control study in China.
Wang M; Gong WW; He QF; Hu RY; Yu M
BMC Womens Health; 2021 Jan; 21(1):13. PubMed ID: 33407401
[TBL] [Abstract] [Full Text] [Related]
7. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract] [Full Text] [Related]
8. Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
Wirth LJ; Tahara M; Robinson B; Francis S; Brose MS; Habra MA; Newbold K; Kiyota N; Dutcus CE; Mathias E; Guo M; Sherman SI; Schlumberger M
Cancer; 2018 Jun; 124(11):2365-2372. PubMed ID: 29656442
[TBL] [Abstract] [Full Text] [Related]
9. Primary Benign and Malignant thyroid Neoplasms With Signet Ring Cells: Cytologic, Histologic, and Molecular Features.
Farhat NA; Onenerk AM; Krane JF; Dias-Santagata D; Sadow PM; Faquin WC
Am J Clin Pathol; 2017 Sep; 148(3):251-258. PubMed ID: 28821194
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel therapeutic targets in anaplastic thyroid carcinoma using functional genomic mRNA-profiling: Paving the way for new avenues?
Jonker PK; van Dam GM; Oosting SF; Kruijff S; Fehrmann RS
Surgery; 2017 Jan; 161(1):202-211. PubMed ID: 27865593
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.
Tiedje V; Ting S; Walter RF; Herold T; Worm K; Badziong J; Zwanziger D; Schmid KW; Führer D
Eur J Endocrinol; 2016 Sep; 175(3):173-80. PubMed ID: 27283290
[TBL] [Abstract] [Full Text] [Related]
12. Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours.
Parker BC; Engels M; Annala M; Zhang W
J Pathol; 2014 Jan; 232(1):4-15. PubMed ID: 24588013
[TBL] [Abstract] [Full Text] [Related]
13. Identification of targetable FGFR gene fusions in diverse cancers.
Wu YM; Su F; Kalyana-Sundaram S; Khazanov N; Ateeq B; Cao X; Lonigro RJ; Vats P; Wang R; Lin SF; Cheng AJ; Kunju LP; Siddiqui J; Tomlins SA; Wyngaard P; Sadis S; Roychowdhury S; Hussain MH; Feng FY; Zalupski MM; Talpaz M; Pienta KJ; Rhodes DR; Robinson DR; Chinnaiyan AM
Cancer Discov; 2013 Jun; 3(6):636-47. PubMed ID: 23558953
[TBL] [Abstract] [Full Text] [Related]
14. Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.
Beadling C; Heinrich MC; Warrick A; Forbes EM; Nelson D; Justusson E; Levine J; Neff TL; Patterson J; Presnell A; McKinley A; Winter LJ; Dewey C; Harlow A; Barney O; Druker BJ; Schuff KG; Corless CL
J Mol Diagn; 2011 Sep; 13(5):504-13. PubMed ID: 21726664
[TBL] [Abstract] [Full Text] [Related]
15. Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia.
Al-Shraim MM; Hussein MR; Musalam AO; Al-Ghandi T; Al-Zahramit H; Mahrouz AA; Abu-Eshy SA
West Afr J Med; 2010; 29(6):398-402. PubMed ID: 21465448
[TBL] [Abstract] [Full Text] [Related]
16. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
[TBL] [Abstract] [Full Text] [Related]
17. Generation of monoclonal antibody targeting fibroblast growth factor receptor 3.
Gorbenko O; Ovcharenko G; Klymenko T; Zhyvoloup O; Gaman N; Volkova D; Gout I; Filonenko V
Hybridoma (Larchmt); 2009 Aug; 28(4):295-300. PubMed ID: 19663703
[TBL] [Abstract] [Full Text] [Related]
18. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
St Bernard R; Zheng L; Liu W; Winer D; Asa SL; Ezzat S
Endocrinology; 2005 Mar; 146(3):1145-53. PubMed ID: 15564323
[TBL] [Abstract] [Full Text] [Related]
19. Mycotic aneurysm of common carotid artery induced by Staphylococcus aureus infection after cervical reoperation.
Machens A; Dralle H
World J Surg; 2001 Sep; 25(9):1113-6. PubMed ID: 11571944
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of fibroblast growth factor receptor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures.
Onose H; Emoto N; Sugihara H; Shimizu K; Wakabayashi I
Eur J Endocrinol; 1999 Feb; 140(2):169-73. PubMed ID: 10069663
[TBL] [Abstract] [Full Text] [Related]
[Next]
